### Contents - [**Articles**](#resources-articles) - [**Discussions**](#resources-discussions) - [**Reports**](#resources-reports) # Pharma and Biotech Software Resources ##### Articles, Discussions, and Reports to expand your knowledge on Pharma and Biotech Software Resource pages are designed to give you a cross-section of information we have on specific categories. You'll find [articles](#resources-articles) from our experts, [discussions](#resources-discussions) from users like you, and [reports](#resources-reports) from industry data. [ContentsExpand/Collapse Contents](#) - [**Articles**](#resources-articles) - [**Discussions**](#resources-discussions) - [**Reports**](#resources-reports) ## Pharma and Biotech Software Articles [![Artificial Intelligence in Healthcare: Benefits, Myths, and Limitations](https://learn.g2.com/hubfs/healthcare%20worker.jpg "Artificial Intelligence in Healthcare: Benefits, Myths, and Limitations")](https://www.g2.com/articles/artificial-intelligence-in-healthcare-benefits-myths-and-limitations) [ ### Artificial Intelligence in Healthcare: Benefits, Myths, and Limitations ](https://www.g2.com/articles/artificial-intelligence-in-healthcare-benefits-myths-and-limitations) Artificial intelligence (AI) is reinventing and reinvigorating the modern healthcare system by finding new links between genetic codes or driving robots that assist with surgery. [ ![Rachael Altman](/assets/transparent-ad5be28fbcd25b7b08d2cebe1d957125437fb5407d75ee717965ad22c8808791.gif "Rachael Altman") RA ](https://learn.g2.com/author/rachael-altman) by Rachael Altman ## Pharma and Biotech Software Discussions 0 Question on: AE Connect [What do small biotechs need to know about ICSR intake for the ICH E2B(R3) deadline?](/discussions/what-do-small-biotechs-need-to-know-about-icsr-intake-for-the-ich-e2b-r3-deadline) The April 1, 2026 FDA deadline for mandatory ICH E2B(R3) electronic ICSR submissions is no longer on the horizon. It is here. If your biotech is still collecting adverse events on paper, in a spreadsheet, or through an unstructured email process, you have a compliance gap that needs immediate attention. Check out this blog: https://aeconnect.io/blog/ich-e2b-r3-deadline-biotech-guide Answered: Daman Singh on March 13, 2026 [Your answer](/discussions/what-do-small-biotechs-need-to-know-about-icsr-intake-for-the-ich-e2b-r3-deadline/comments/new?remote=true) 0 Question on: Veeva Vault RIM [Is Veeva Vault a validated system?](/discussions/veeva-vault-rim-is-veeva-vault-a-validated-system) Is Veeva Vault a validated system? Yes, it is a GxP and Validated system. Answered: Darewin Mendonsa on March 6, 2024 [Your answer](/discussions/veeva-vault-rim-is-veeva-vault-a-validated-system/comments/new?remote=true) 0 Question on: Veeva Vault RIM [What is vault PromoMats?](/discussions/veeva-vault-rim-what-is-vault-promomats) What is vault PromoMats? In the Pharmaceutical Industry, there are many strict regulations on the promotional materials that is used for the promotion of medicines. These materials need approval from health authority and regular updates done also need to be cascaded to field workers. This lifecycle is carefully maintained via Vault PromoMats. It is a crucial tool because patient safety is involved and no compromise is acceptable. Note: drugs and medicinal products are not allowed to be marketed to general public. So I am referring to the promotional and advertisement materials used by Medical Reps for Doctors. Answered: Darewin Mendonsa on May 14, 2024 [Your answer](/discussions/veeva-vault-rim-what-is-vault-promomats/comments/new?remote=true) - ‹ Prev‹ Prev - 1 - [2](/categories/pharma-and-biotech/resources?discussions_page=2) - [3](/categories/pharma-and-biotech/resources?discussions_page=3) - [Next ›Next ›](/categories/pharma-and-biotech/resources?discussions_page=2) ## Pharma and Biotech Software Reports Grid® Report for Pharma and Biotech Summer 2026 G2 Report: Grid® Report Momentum Grid® Report for Pharma and Biotech Summer 2026 G2 Report: Momentum Grid® Report Mid-Market Grid® Report for Pharma and Biotech Summer 2026 G2 Report: Grid® Report Momentum Grid® Report for Pharma and Biotech Spring 2026 G2 Report: Momentum Grid® Report Mid-Market Grid® Report for Pharma and Biotech Spring 2026 G2 Report: Grid® Report Grid® Report for Pharma and Biotech Spring 2026 G2 Report: Grid® Report Momentum Grid® Report for Pharma and Biotech Winter 2026 G2 Report: Momentum Grid® Report Grid® Report for Pharma and Biotech Winter 2026 G2 Report: Grid® Report Mid-Market Grid® Report for Pharma and Biotech Winter 2026 G2 Report: Grid® Report